NCT05053100View on ClinicalTrials.gov

Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

July 5, 2024

Study Completion Date

July 5, 2024

Conditions
Acute LeukemiaDeep Vein ThrombosisHematopoietic and Lymphoid Cell NeoplasmHodgkin LymphomaMyeloproliferative NeoplasmNon-Hodgkin LymphomaPlasma Cell MyelomaThrombocytopenia
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood

OTHER

Electronic Health Record Review

Undergo electronic health record review

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05053100 - Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study | Biotech Hunter | Biotech Hunter